Legend Biotech (LEGN) Amortization of Goodwill (2024 - 2025)

Legend Biotech (LEGN) posted Amortization of Goodwill of $970000.0 for Q1 2025, down 78.07% on a QoQ basis from $4.4 million in Q4 2024.

Legend Biotech (LEGN) Amortization of Goodwill (2024 - 2025) Analysis & Trends

Legend Biotech's Amortization of Goodwill history runs 2 years deep, the most recent figure standing at $970000.0 for Q1 2025.

Quarterly Amortization of Goodwill changed N/A year-over-year to $970000.0 in Q1 2025, while the trailing twelve-month figure through Jun 2025 was $5.4 million (changed N/A YoY) and the FY2024 annual result came in at $4.4 million, changed N/A from the prior year.
Amortization of Goodwill was $970000.0 for Q1 2025 at Legend Biotech, down from $4.4 million in the prior quarter.
Across five years, Amortization of Goodwill topped out at $4.4 million in Q4 2024 and bottomed at $970000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-
10	Legend Biotech	8.26 Bn	7.36 Bn	-

Download Data